M

Marinomed Biotech AG
VSE:MARI

Watchlist Manager
Marinomed Biotech AG
VSE:MARI
Watchlist
Price: 18.8 EUR -1.05% Market Closed
Market Cap: 34.6m EUR

Intrinsic Value

The intrinsic value of one MARI stock under the Base Case scenario is 26.44 EUR. Compared to the current market price of 18.8 EUR, Marinomed Biotech AG is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MARI Intrinsic Value
26.44 EUR
Undervaluation 29%
Intrinsic Value
Price
M
Base Case Scenario

Valuation History
Marinomed Biotech AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about MARI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MARI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Marinomed Biotech AG.

Explain Valuation
Compare MARI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MARI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Marinomed Biotech AG

Current Assets 3m
Cash & Short-Term Investments 1.5m
Receivables 1.3m
Other Current Assets 244.3k
Non-Current Assets 4.7m
PP&E 4.6m
Intangibles 16.7k
Other Non-Current Assets 100
Current Liabilities 3.6m
Accounts Payable 283.5k
Other Current Liabilities 3.3m
Non-Current Liabilities 9.5m
Long-Term Debt 7.4m
Other Non-Current Liabilities 2.1m
Efficiency

Free Cash Flow Analysis
Marinomed Biotech AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Marinomed Biotech AG

Revenue
11.9m EUR
Cost of Revenue
-5.1m EUR
Gross Profit
6.9m EUR
Operating Expenses
6.5m EUR
Operating Income
13.4m EUR
Other Expenses
-8.1m EUR
Net Income
5.3m EUR
Fundamental Scores

MARI Profitability Score
Profitability Due Diligence

Marinomed Biotech AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional Operating Margin
ROIC is Increasing
54/100
Profitability
Score

Marinomed Biotech AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

MARI Solvency Score
Solvency Due Diligence

Marinomed Biotech AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
47/100
Solvency
Score

Marinomed Biotech AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MARI Price Targets Summary
Marinomed Biotech AG

Wall Street analysts forecast MARI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MARI is 52.02 EUR with a low forecast of 51.51 EUR and a high forecast of 53.55 EUR.

Lowest
Price Target
51.51 EUR
174% Upside
Average
Price Target
52.02 EUR
177% Upside
Highest
Price Target
53.55 EUR
185% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MARI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MARI stock?

The intrinsic value of one MARI stock under the Base Case scenario is 26.44 EUR.

Is MARI stock undervalued or overvalued?

Compared to the current market price of 18.8 EUR, Marinomed Biotech AG is Undervalued by 29%.

Back to Top